Trademarkia Logo

Canada

C$
Trademark Search in Canada
RYSTIGGO (DESIGN)

View On IC.GC.CA

RYSTIGGO (DESIGN)
REGISTERED

on 30 Sept 2024

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

UCB BIOPHARMA SRL

Allée de la Recherche 60B-1070 Brussels,

BE

Serial Number

2239130 filed on 10th Feb 2023

Registration Number

TMA1259874 registered on 30th Sept 2024

Registration expiry Date

30th Sept 2034

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

RYSTIGGO (DESIGN)

Trademark usage description

pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparat Read More

Vienna Information

24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for use in the treatment of immunological disorders; pharmaceutical preparations for the treatment of neurological diseases, namely, myasthenia gravis, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases.

Classification kind code

12

Mark Details

Serial Number

2239130

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 30th Sept 2024		Registration Pending
Submitted for opposition 42
on 10th Jul 2024		Advertised
Submitted for opposition 26
on 12th Jun 2024		Approved
Submitted for opposition 27
on 12th Jun 2024		Approval Notice Sent
Submitted for opposition 22
on 4th Jun 2024		Search Recorded
Submitted for opposition 67
on 15th Dec 2023		Agent Name Changed
Submitted for opposition 287
on 23rd Feb 2023		Pre-Assessment Letter Sent
Submitted for opposition 30
on 10th Feb 2023		Filed
Submitted for opposition 1
on 10th Feb 2023		Created
Submitted for opposition 31
on 10th Feb 2023		Formalized

This website uses cookies

We use cookies to ensure you get the best experience. Check our Privacy Policy and Terms & Conditions.
Manage cookies

Manage cookies

You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.

Advertisement

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously

Analytics

Analytical cookies are used to understand how visitors interact with the website.

Functional

Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website.